{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:15:39Z","timestamp":1781010939515,"version":"3.54.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Patients with non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) often suffer from chronic rhinosinusitis (CRS) with nasal polyps, a form of primary diffuse Type 2 CRS. Although this disease is also seen in NSAID-tolerant patients, CRS in N-ERD often is more severe and more treatment resistant; local nasal therapy (nasal corticosteroids) and endoscopic sinus surgery are employed like in NSAID-tolerant patients, but with limited and\/or short-lived effects. This mini-review gives an overview of the current additional treatment options for CRS in N-ERD. As such diets, aspirin therapy after desensitization, antileukotriene therapy and biologicals are discussed based on the current body of literature. Selecting the right treatment strategy depends on shared-decision making, local availability and cooperation between ENT-surgeons, allergists, and pulmonologists.<\/jats:p>","DOI":"10.3389\/falgy.2021.734000","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T05:36:02Z","timestamp":1629783362000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients"],"prefix":"10.3389","volume":"2","author":[{"given":"Rik J. L.","family":"van der Lans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sietze","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.601","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2013an underestimated disease. A GA(2)LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/all.13042","article-title":"Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample","volume":"72","author":"Hirsch","year":"2017","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4193\/Rhin18.061","article-title":"Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study","volume":"57","author":"Ostovar","year":"2019","journal-title":"Rhinology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","article-title":"Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology","volume":"143","author":"Dietz de Loos","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/all.14106","article-title":"Radiologic sinus inflammation and symptoms of chronic rhinosinusitis in a population-based sample","volume":"75","author":"Hirsch","year":"2020","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1398-9995.2010.02503.x","article-title":"Reliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis\u2013a GA(2) LEN study","volume":"66","author":"Tomassen","year":"2011","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4193\/RHINOL\/20.092","article-title":"Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps","volume":"58","author":"Lourijsen","year":"2020","journal-title":"Rhinology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00043764-200301000-00007","article-title":"The health and productivity cost burden of the \u201ctop 10\u201d physical and mental health conditions affecting six large U.S. employers in 1999","volume":"45","author":"Goetzel","year":"2003","journal-title":"J Occup Environ Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4193\/RHINOL\/18.067","article-title":"Assessing quality of life and burden of disease in chronic rhinosinusitis: a review","volume":"2","author":"Klonaris","year":"2019","journal-title":"Rhinol Online"},{"key":"B11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4193\/Rhin19.158","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4193\/RHINOL\/19.009","article-title":"Nasal symptoms in patients with NSAID hypersensitivity","volume":"2","author":"Lange","year":"2019","journal-title":"Rhinol Online"},{"key":"B13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12931-018-0823-y","article-title":"Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study","volume":"19","author":"Philpott","year":"2018","journal-title":"Respir Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/all.12941","article-title":"Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA(2) LEN) survey","volume":"71","author":"Makowska","year":"2016","journal-title":"Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jaci.2016.09.025","article-title":"Aspirin-exacerbated respiratory disease: mediators and mechanisms of a clinical disease","volume":"139","author":"Cahill","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4193\/Rhin19.423","article-title":"Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID - intolerance","volume":"58","author":"Steiner","year":"2020","journal-title":"Rhinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4193\/Rhin20.165","article-title":"The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgery","volume":"58","author":"Reitsma","year":"2020","journal-title":"Rhinology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4193\/Rhin19.184","article-title":"Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma","volume":"58","author":"Zhang","year":"2020","journal-title":"Rhinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4193\/Rhin19.258","article-title":"Evaluation of the effect of endoscopic partial middleturbinectomy surgery on the quality of life of patients with chronic rhinosinusitis and nasal polyps","volume":"58","author":"Delarestaghi","year":"2020","journal-title":"Rhinology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4193\/Rhin19.430","article-title":"The burden of non-steroidal anti-inflammatory exacerbated respiratory disease from the patient's perspective - a qualitative analysis of posts from the Samter's Society","volume":"58","author":"Alanin","year":"2020","journal-title":"Rhinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/alr.21678","article-title":"A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial","volume":"6","author":"Sommer","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/nu13030991","article-title":"Effectiveness of personalized low salicylate diet in the management of salicylates hypersensitive patients: interventional study","volume":"13","author":"Keszycka","year":"2021","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaip.2017.10.011","article-title":"Dietary fatty acid modification for the treatment of aspirin-exacerbated respiratory disease: a prospective pilot trial","volume":"6","author":"Schneider","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.iac.2012.10.013","article-title":"Aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"33","author":"White","year":"2013","journal-title":"Immunol Allergy Clin North Am"},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4193\/Rhino09.113","article-title":"Aspirin desensitization for ASA triad patients\u2013prospective study of the rhinologist\u2018s perspective","volume":"49","author":"Forer","year":"2011","journal-title":"Rhinology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.anl.2018.12.002","article-title":"Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: a prospective cohort study","volume":"46","author":"Cooper","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"B30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0194599814545750","article-title":"Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease","volume":"151","author":"Cho","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/alr.22036","article-title":"Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"8","author":"Adappa","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B32","first-page":"1639","article-title":"Clinical and immunological efficacy of aspirin desensitization in nasal polyp patients with aspirin-exacerbated respiratory disease","volume":"16","author":"Mortazavi","year":"2017","journal-title":"Iran J Pharm Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clim.2015.05.012","article-title":"Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: a randomized double-blind placebo-controlled trial","volume":"160","author":"Esmaeilzadeh","year":"2015","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/all.12131","article-title":"Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease","volume":"68","author":"Fruth","year":"2013","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1016\/j.jaip.2020.06.063","article-title":"High discontinuation rates of peroral ASA treatment for CRSwNP: a real-world multicenter study of 171 N-ERD patients","volume":"8","author":"Laulajainen-Hongisto","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000499134","article-title":"The effect of antileukotrienes on the results of postoperative treatment of paranasal sinuses in patients with non-steroidal anti-inflammatory drug-exacerbated respiratory disease","volume":"179","author":"Stryjewska-Makuch","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/1945892419873211","article-title":"Effect of Zileuton treatment on sinonasal quality of life in patients with aspirin-exacerbated respiratory disease","volume":"33","author":"Lee","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.26355\/eurrev_201909_19031","article-title":"Omalizumab treatment in Samter's triad: case series and review of the literature","volume":"23","author":"Cameli","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4193\/Rhin19.318","article-title":"Omalizumab in patients with NSAIDs-exacerbated respiratory disease","volume":"58","author":"Forster-Ruhrmann","year":"2020","journal-title":"Rhinology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaip.2018.01.038","article-title":"A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease","volume":"6","author":"Tuttle","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.22541\/au.159974658.89695391","article-title":"State-of-the-art overview on biological treatment for CRSwNP","volume":"59","author":"Hellings","year":"2021","journal-title":"Rhinology"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.734000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T05:36:05Z","timestamp":1629783365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.734000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":47,"alternative-id":["10.3389\/falgy.2021.734000"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2021.734000","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"article-number":"734000"}}